99 related articles for article (PubMed ID: 2617375)
1. [Adjuvant M-VEC in advanced urotheliomas of the bladder].
Cocimano V; Marino G; Brigato R; Pacilli N; Buffa G; Marten Perolino R
Minerva Urol Nefrol; 1989; 41(3):195-7. PubMed ID: 2617375
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
4. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
Rassweiler J; Rüther U; Bäuerle K; Bub P; Jipp P; Eisenberger F
Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
[TBL] [Abstract][Full Text] [Related]
5. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
Tsai YS; Tzai TS; Chow NH
Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
[TBL] [Abstract][Full Text] [Related]
6. [The M-VEC chemotherapy of advanced bladder tumors].
Kumanov Kh; Ormanov I; Tsvetkov M; Donovski L
Khirurgiia (Sofiia); 1989; 42(6):39-45. PubMed ID: 2634800
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].
Marino G; Cocimano V; Cevoli R; Marten Perolino R
Minerva Urol Nefrol; 1993 Sep; 45(3):113-5. PubMed ID: 8278877
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II pilot study on the efficacy and tolerability of neoadjuvant chemotherapy (Rescue M-VEC) and preoperative radiation therapy for infiltrating bladder cancer: results of an 18-month follow-up.
Voce S; Montanari F; Arnone S; Dal Pozzo C; Suprani G; Cerullo G; Fornarola V
Arch Esp Urol; 1992 Jun; 45(5):491-8. PubMed ID: 1510485
[TBL] [Abstract][Full Text] [Related]
9. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.
Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1992 Aug; 148(2 Pt 1):302-6; discussion 306-7. PubMed ID: 1635123
[TBL] [Abstract][Full Text] [Related]
10. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.
Frassoldati A; Federico M; Barbieri F; Brausi M; Pollastri C; Berri G; Castagnetti G; Palladini PP; Silingardi V
Med Oncol Tumor Pharmacother; 1991; 8(2):99-103. PubMed ID: 1749307
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant systemic chemotherapy with VMC (vinblastine, methotrexate and cisplatin) in locally advanced carcinoma of the bladder].
Maffezzini M; Rigatti P
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):219-21. PubMed ID: 2142804
[TBL] [Abstract][Full Text] [Related]
13. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy of infiltrating carcinoma of the bladder: our experience].
Graziotti P; Personeni A; Benzone S; Giannone C; Giardina G; Guizzetti C; Ranieri A; Romano C; Taino R; Lembo A
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):223-9. PubMed ID: 2142805
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative chemotherapy of locally disseminated cancer of the urinary bladder using methotrexate, vinblastine, platidiam and farmorubicin].
Matveev BP; Gadzhiev NG; Chevelidze ShG
Urol Nefrol (Mosk); 1988; (2):38-41. PubMed ID: 3164537
[No Abstract] [Full Text] [Related]
18. MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.
Hoffmann AC; Wild P; Leicht C; Bertz S; Danenberg KD; Danenberg PV; Stöhr R; Stöckle M; Lehmann J; Schuler M; Hartmann A
Neoplasia; 2010 Aug; 12(8):628-36. PubMed ID: 20689757
[TBL] [Abstract][Full Text] [Related]
19. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limits of chemotherapy in multi-modality treatment of urinary bladder cancer].
Rüther U; Rassweiler J; Lüthgens M; Bub P; Jipp P; Eisenberger F
Verh Dtsch Ges Inn Med; 1989; 95():544-52. PubMed ID: 2603494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
